Literature DB >> 23380012

Osteosarcoma and chondrosarcoma of the shoulder: site-specific comparative analysis.

Seung Han Shin1, Hyeon Jang Jeong, Ilkyu Han, Hwan Seong Cho, Han-Soo Kim.   

Abstract

Osteosarcoma and chondrosarcoma compose most of the primary malignancies of the shoulder. The literature lacks site-specific comparative analyses of these 2 major shoulder sarcomas. The purposes of this study were to describe the different characteristics of the 2 major sarcomas near the glenohumeral joint, examine differences in treatment outcomes, and evaluate the functional outcomes of limb salvage surgery. Thirty-two patients with osteosarcoma or chondrosarcoma who underwent a wide resection including the glenohumeral joint were enrolled in this study. The characteristics of tumor development and treatment, oncologic and functional outcomes, and factors affecting outcomes were compared between groups and with the literature. The results showed shoulder osteosarcoma developing similarly to the literature reports, whereas chondrosarcoma tended to be of a high histologic grade. Nonetheless, the osteosarcoma group had a poorer overall 5-year survival rate (53.0%) than the chondrosarcoma group (85.7%) or those in previous reports. The osteosarcoma group had a tendency toward a worse 5-year metastasis-free survival rate than the chondrosarcoma group (35.4% vs 75.0%, respectively), although the 5-year local recurrence-free survival rate was not significantly different between the 2 groups (75.0% vs 87.5%, respectively). Histologic grade, surgical stage, and chemotherapy affected the oncologic outcomes in univariate analysis, although not a single factor was independent in multivariate analysis. The functional outcomes were not significantly affected by clinical characteristics or surgical methods in patients who had undergone a wide resection including the glenohumeral joint. Copyright 2013, SLACK Incorporated.

Entities:  

Mesh:

Year:  2013        PMID: 23380012     DOI: 10.3928/01477447-20130122-20

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  6 in total

1.  Effect of DEC1 on the proliferation, adhesion, invasion and epithelial-mesenchymal transition of osteosarcoma cells.

Authors:  Shuai Li; Dan Peng; Zi-Qing Yin; Wei Zhu; Xuan-Tao Hu; Cong-Wei Liu
Journal:  Exp Ther Med       Date:  2020-01-17       Impact factor: 2.447

Review 2.  The role of extracelluar matrix in osteosarcoma progression and metastasis.

Authors:  Juncheng Cui; Dylan Dean; Francis J Hornicek; Zhiwei Chen; Zhenfeng Duan
Journal:  J Exp Clin Cancer Res       Date:  2020-09-04

3.  COL5A2 Inhibits the TGF-β and Wnt/β-Catenin Signaling Pathways to Inhibit the Invasion and Metastasis of Osteosarcoma.

Authors:  Yan-Long Han; Dan Luo; Kakeng Habaxi; Julaiti Tayierjiang; Wei Zhao; Wei Wang; Wumaierjiang Aikebaier; Li Wang
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

4.  Malawer limb salvage surgery for the treatment of scapular chondrosarcoma.

Authors:  Fei Chang; Guang-Yao Liu; Qiao Zhang; Gang Lin; Hong Huang; De-Sheng Duan; Jin-Cheng Wang
Journal:  World J Surg Oncol       Date:  2014-06-30       Impact factor: 2.754

Review 5.  Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment.

Authors:  Jing Li; Zuozhang Yang; Yi Li; Junfeng Xia; Dongqi Li; Huiling Li; Mingyan Ren; Yedan Liao; Shunling Yu; Yanjin Chen; Yihao Yang; Ya Zhang
Journal:  Oncotarget       Date:  2016-07-12

Review 6.  The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis.

Authors:  George N Tzanakakis; Eirini-Maria Giatagana; Aikaterini Berdiaki; Ioanna Spyridaki; Kyoko Hida; Monica Neagu; Aristidis M Tsatsakis; Dragana Nikitovic
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.